ONCORENA
ONCORENA
Industry:
Biotechnology Health Care Therapeutics
Founded:
2011-01-01
Address:
Lund, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.oncorena.com
Total Employee:
1+
Status:
Active
Total Funding:
80.5 M SEK
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API WordPress Mobile Non Scaleable Content Euro WordPress 6.0 GStatic Google Static Content WP Super Cache EU Cookie Law
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Kara Connect
Kara Connect is a secure digital workstation for professionals in Health, Education and Welfare
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
Linc AB
Linc AB investment in Venture Round - Oncorena
HealthCap
HealthCap investment in Venture Round - Oncorena
FÃ¥hraeus Startup and Growth
FÃ¥hraeus Startup and Growth investment in Venture Round - Oncorena
HealthCap
HealthCap investment in Venture Round - Oncorena
Partners for Development investments in Life Sciences
Partners for Development investments in Life Sciences investment in Venture Round - Oncorena
Official Site Inspections
http://www.oncorena.com Semrush global rank: 5.25 M Semrush visits lastest month: 1.56 K
- Host name: 185.133.206.199
- IP address: 185.133.206.199
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
More informations about "Oncorena"
Oncorea.com
Oncorea.com est un site qui s'adresse aux étudiants en médecine, aux médecins se spécialisant et aux élèves-infirmières SIAMU à la recherche d'informations concernant la Réanimation …See details»
About Oncorena - Home
About Oncorena. Oncorena AB is a Swedish pharmaceutical company founded in 2011, in Gothenburg, with the mission to develop a breakthrough treatment for metastatic renal cancer …See details»
Oncorena - Crunchbase Company Profile & Funding
Oncorena is a pharmaceutical company that is working on a treatment for advanced kidney cancer (metastatic renal cancer). Its goal is to confirm orellanine's potent anti-tumor activity …See details»
Home - Home
Oncorena breaks new ground in developing an innovative treatment for patients with metastatic renal cancer. About one-third of kidney cancer patients are diagnosed with this fatal disease …See details»
Oncorena - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 22, 2025 Oncorena - Swedish oncology company developing a potentially curative therapy for metastatic renal cancer.. Raised funding from 1 investor. Founded by Jenny Nystrom in the …See details»
Oncorena AB - LinkedIn
Oncorena AB | 651 followers on LinkedIn. Developing a first-in-class treatment for advanced renal cancer | Oncorena is aiming to save human lives by transforming a natural substance into a ...See details»
Oncorena - Overview, News & Similar companies | ZoomInfo.com
Oncorena Receives Approval of First in Patient Trial with Orellanine as a Potential Breakthrough Therapy in Metastatic Renal Cancer Patients LUND, SWEDEN, March 1, 2021 - Oncorena, …See details»
Oncorena 2025 Company Profile: Valuation, Funding & Investors
Oncorena General Information Description. Developer of anti-tumor drugs designed for metastatic renal cancer. The company's product includes the toxin orellanine, naturally found in specific …See details»
Oncorena AB:Company Profile & Technical Research,Competitor …
Oncorena AB is a company that provides Clear cell, Medicine, Pharmacy and Therapeutics and more. Oncorena AB is headquartered in Sweden . Oncorena AB was founded in 2011.See details»
Oncorea.com
- 20ème RENCONTRE EVELINE MARKIEWICZ sur les URGENCES ET COMPLICATIONS SÉVÈRES CHEZ LE PATIENT CANCÉREUX Thèmes: Support vital en soins intensifs …See details»
Oncorena Company Profile - Craft
Oncorena has 5 employees at their 1 location. See insights on Oncorena including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Oncorena - Products, Competitors, Financials, Employees, …
About Oncorena. Oncorena is a pharmaceutical company focused on developing a breakthrough treatment for metastatic renal cancer. The company's main offering is a synthetic version of …See details»
Oncorena - VentureRadar
Website: https://www.oncorena.se/ Oncorena AB is a Swedish pharmaceutical company founded in 2011, in Gothenburg, with the mission to develop a breakthrough treatment ...See details»
News - Home
2023-11-22. Börje Haraldsson – CEO at Oncorena. In 2011, the pharmaceutical company Oncorena was founded with the mission to develop a breakthrough treatm…See details»
Oncological emergencies - Jules Bordet Institute
The department managers have developed a specific website on resuscitation and oncological emergencies: www.oncorea.com. Teaching The department has a continuous intake of …See details»
Oncorena Secures Financing of the Company's Continued …
LUND, Sweden, Dec. 23, 2021 /PRNewswire/ -- Oncorena, developing a potential breakthrough therapy for advanced renal cancer, receives a capital injection of MSEK 66 from one of the …See details»
Soins cancérologiques urgents | Institut Jules Bordet
Jan 17, 2025 Les responsables de l’unité ont développé un site spécifique sur la réanimation et les urgences oncologiques : www.oncorea.com. Enseignement Le service accueille en …See details»
Oncorena Secures Financing of Development of Orellanine, a …
LUND, SWEDEN, December 23, 2021 – Oncorena, developing a potential breakthrough therapy for advanced renal cancer, receives a capital injection of MSEK 66 from one of the company’s …See details»
Soins Intensifs - Institut Jules Bordet
Les responsables de l’unité ont développé un site spécifique sur la réanimation oncologique : www.oncorea.com Enseignement Le service accueille en permanence des étudiants en …See details»
Oncorena Receives Approval of First in Patient Trial with …
LUND, Sweden, March 1, 2021 /PRNewswire/ -- Oncorena, dedicated to developing a unique and potential breakthrough therapy for metastatic renal cancer, today announces the Swedish …See details»